NO20030524L - Vaksine mot vertscelleassosiert herpesvirus - Google Patents

Vaksine mot vertscelleassosiert herpesvirus

Info

Publication number: NO20030524L
Authority: NO; Norway
Prior art keywords: host cell; herpes virus; vaccine against; against host; associated herpes
Prior art date: 2000-08-03

Application number

NO20030524A

Other languages

English (en)

Other versions

NO20030524D0 (no

NO332621B1 (no

Inventor

Frank Fehler

Kaus Osterrieder

Original Assignee

Lohmann Animal Health Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2003-02-03

Publication date

2003-04-03

2003-02-03 Application filed by Lohmann Animal Health Gmbh filed Critical Lohmann Animal Health Gmbh

2003-02-03 Publication of NO20030524D0 publication Critical patent/NO20030524D0/no

2003-04-03 Publication of NO20030524L publication Critical patent/NO20030524L/no

2012-11-19 Publication of NO332621B1 publication Critical patent/NO332621B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20030524A 2000-08-03 2003-02-03 Vaksine mot Mareks sykdom, rekombinant genom fra Mareks sykdomsvirus samt anvendelse derav for fremstilling av medikamenter mot Mareks sykdom. NO332621B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00202757A EP1178111A1 (en)	2000-08-03	2000-08-03	Vaccination against host cell-associated herpesviruses
PCT/EP2001/008893 WO2002012288A2 (en)	2000-08-03	2001-08-01	Vaccination against host cell-associated herpesviruses

Publications (3)

Publication Number	Publication Date
NO20030524D0 NO20030524D0 (no)	2003-02-03
NO20030524L true NO20030524L (no)	2003-04-03
NO332621B1 NO332621B1 (no)	2012-11-19

Family

ID=8171884

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030524A NO332621B1 (no)	2000-08-03	2003-02-03	Vaksine mot Mareks sykdom, rekombinant genom fra Mareks sykdomsvirus samt anvendelse derav for fremstilling av medikamenter mot Mareks sykdom.

Country Status (24)

Country	Link
US (1)	US9073979B2 (no)
EP (2)	EP1178111A1 (no)
JP (1)	JP4313036B2 (no)
KR (1)	KR100633180B1 (no)
CN (2)	CN102151333A (no)
AT (1)	ATE412055T1 (no)
AU (2)	AU9171601A (no)
BR (1)	BRPI0112989B1 (no)
CA (1)	CA2417923C (no)
CZ (1)	CZ303904B6 (no)
DE (1)	DE60136278D1 (no)
EA (1)	EA010721B1 (no)
ES (1)	ES2315306T3 (no)
HR (1)	HRP20030147B1 (no)
HU (1)	HU228262B1 (no)
IL (2)	IL154250A0 (no)
MX (1)	MXPA03001027A (no)
NO (1)	NO332621B1 (no)
NZ (1)	NZ524066A (no)
PL (1)	PL207958B1 (no)
PT (1)	PT1307565E (no)
UA (1)	UA84667C2 (no)
WO (1)	WO2002012288A2 (no)
ZA (1)	ZA200300842B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1178111A1 (en)	2000-08-03	2002-02-06	Lohmann Animal Health GmbH & Co. KG	Vaccination against host cell-associated herpesviruses
JPWO2005085445A1 (ja) *	2004-03-05	2007-12-13	財団法人阪大微生物病研究会	組換え水痘帯状疱疹ウイルス
US9273326B2 (en)	2004-04-30	2016-03-01	The Brigham And Women's Hospital, Inc.	Tetracycline-regulated gene expression in HSV-1 vectors
US20080226677A1 (en) *	2004-05-06	2008-09-18	Yasuko Mori	Recombinant virus vector for gene transfer into lymphoid cells
MX2011012347A (es)	2009-05-22	2012-02-21	Genocea Biosciences Inc	Vacunas contra virus del herpes simple tipo 2: composiciones y metodos para obtener una respuesta inmunitaria.
EP2516629B1 (en) *	2009-12-21	2016-04-13	The Brigham and Women's Hospital, Inc.	Herpes simplex virus vaccines
AU2011336894B2 (en) *	2010-11-24	2016-11-17	Genocea Biosciences, Inc.	Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
MY173856A (en) *	2011-10-21	2020-02-25	Intervet Int Bv	Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
JP6199878B2 (ja) *	2011-11-23	2017-09-20	ジェノセアバイオサイエンシーズ，インコーポレイテッド	単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
CN105561303B (zh) *	2015-12-30	2019-04-05	暨南大学	单纯疱疹病毒i型ul5基因缺失的dna疫苗的制备方法
CN105597095A (zh) *	2015-12-30	2016-05-25	暨南大学	一种应用微载体培养Vero细胞制备基因缺失减毒疫苗的方法
CN105641692A (zh) *	2015-12-30	2016-06-08	暨南大学	单纯疱疹病毒ⅰ型基因重组减毒活疫苗及其制备方法
WO2018064232A1 (en)	2016-09-28	2018-04-05	Genocea Biosciences, Inc.	Methods and compositions for treating herpes
US11174322B2 (en) *	2017-07-24	2021-11-16	INSERM (Institut National de la Santé et de la Recherche Médicale)	Antibodies and peptides to treat HCMV related diseases
US11291715B2 (en) *	2017-12-20	2022-04-05	Intervet Inc.	Diluent for cell-associated alphaherpesvirus vaccine
WO2019152821A1 (en)	2018-02-05	2019-08-08	The Brigham And Women's Hospital, Inc.	Recombinant herpes simplex virus-2 expressing glycoprotein b and d antigens

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3959466A (en) *	1974-04-15	1976-05-25	The Wistar Institute	Highly attenuated cytomegalovirus vaccine and production thereof
GB8821441D0 (en)	1988-09-13	1988-10-12	Animal Health Inst	Viral vectors
EP0486106A3 (en)	1990-11-16	1992-12-23	Akzo N.V.	Marek's disease virus vaccine
AU657144B2 (en) *	1991-07-09	1995-03-02	Juridical Foundation The Chemo-Sero-Therapeutic Research Institute	Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
JP3675569B2 (ja)	1995-04-28	2005-07-27	日本ゼオン株式会社	組み換えウイルス及びそれよりなるワクチン
JPH11509099A (ja)	1995-07-07	1999-08-17	日本ゼオン株式会社	マレック病ウイルス遺伝子およびマレック病に対する防御のためのワクチンにおけるそれらの使用
US6306387B1 (en) *	1997-05-29	2001-10-23	The Research Foundation Of State University Of New York	Antigen delivery system
DE19733364A1 (de) *	1997-08-01	1999-02-04	Koszinowski Ulrich H Prof	Verfahren zur Klonierung eines großen Virusgenoms
AUPP684998A0 (en) *	1998-10-30	1998-11-26	Murdoch Institute for Research into Birth Defects Limited, The	A method of recombination and agents useful for same
EP1038952A3 (en)	1998-12-09	2001-06-27	Pfizer Products Inc.	Processes for preparation of Marek's Disease Virus using continuous avian cell lines
US6410222B1 (en) *	1998-12-14	2002-06-25	Juridical Foundation The Chemosero-Therapeutic Research Institute	In ovo vaccination of marek's disease type I virus
US6299882B1 (en)	1999-04-09	2001-10-09	Schering Corporation	UL54.5 of Marek's disease virus (MDV)
EP1178111A1 (en)	2000-08-03	2002-02-06	Lohmann Animal Health GmbH & Co. KG	Vaccination against host cell-associated herpesviruses

2000
- 2000-08-03 EP EP00202757A patent/EP1178111A1/en not_active Withdrawn
2001
- 2001-01-08 UA UA2003021829A patent/UA84667C2/ru unknown
- 2001-08-01 AU AU9171601A patent/AU9171601A/xx active Pending
- 2001-08-01 PT PT01971839T patent/PT1307565E/pt unknown
- 2001-08-01 CA CA2417923A patent/CA2417923C/en not_active Expired - Lifetime
- 2001-08-01 MX MXPA03001027A patent/MXPA03001027A/es active IP Right Grant
- 2001-08-01 KR KR1020037001366A patent/KR100633180B1/ko not_active Expired - Lifetime
- 2001-08-01 BR BRPI0112989A patent/BRPI0112989B1/pt active IP Right Grant
- 2001-08-01 CZ CZ20030324A patent/CZ303904B6/cs not_active IP Right Cessation
- 2001-08-01 HU HU0302664A patent/HU228262B1/hu unknown
- 2001-08-01 HR HR20030147A patent/HRP20030147B1/xx not_active IP Right Cessation
- 2001-08-01 PL PL365190A patent/PL207958B1/pl unknown
- 2001-08-01 WO PCT/EP2001/008893 patent/WO2002012288A2/en not_active Ceased
- 2001-08-01 DE DE60136278T patent/DE60136278D1/de not_active Expired - Lifetime
- 2001-08-01 EA EA200300215A patent/EA010721B1/ru not_active IP Right Cessation
- 2001-08-01 IL IL15425001A patent/IL154250A0/xx unknown
- 2001-08-01 ES ES01971839T patent/ES2315306T3/es not_active Expired - Lifetime
- 2001-08-01 CN CN2011100310998A patent/CN102151333A/zh active Pending
- 2001-08-01 AT AT01971839T patent/ATE412055T1/de active
- 2001-08-01 JP JP2002518259A patent/JP4313036B2/ja not_active Expired - Lifetime
- 2001-08-01 EP EP01971839A patent/EP1307565B1/en not_active Expired - Lifetime
- 2001-08-01 AU AU2001291716A patent/AU2001291716B2/en not_active Ceased
- 2001-08-01 CN CNA018167950A patent/CN1503843A/zh active Pending
- 2001-08-01 NZ NZ524066A patent/NZ524066A/en not_active IP Right Cessation
2003
- 2003-01-30 ZA ZA200300842A patent/ZA200300842B/en unknown
- 2003-01-30 US US10/354,932 patent/US9073979B2/en active Active
- 2003-02-02 IL IL154250A patent/IL154250A/en not_active IP Right Cessation
- 2003-02-03 NO NO20030524A patent/NO332621B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO20030524D0 (no)	2003-02-03
PL207958B1 (pl)	2011-02-28
AU2001291716B2 (en)	2007-06-07
UA84667C2 (ru)	2008-11-25
CN1503843A (zh)	2004-06-09
DE60136278D1 (de)	2008-12-04
WO2002012288A2 (en)	2002-02-14
IL154250A0 (en)	2003-09-17
ZA200300842B (en)	2004-04-30
EP1307565B1 (en)	2008-10-22
HU228262B1 (en)	2013-02-28
BR0112989A (pt)	2003-09-09
MXPA03001027A (es)	2004-02-26
AU9171601A (en)	2002-02-18
CA2417923A1 (en)	2002-02-14
HRP20030147B1 (en)	2011-10-31
ES2315306T3 (es)	2009-04-01
AU2001291716B8 (en)	2002-02-18
NO332621B1 (no)	2012-11-19
CA2417923C (en)	2010-06-29
BRPI0112989B1 (pt)	2015-09-08
IL154250A (en)	2013-07-31
EP1178111A1 (en)	2002-02-06
CZ2003324A3 (cs)	2003-06-18
JP4313036B2 (ja)	2009-08-12
KR20030036657A (ko)	2003-05-09
HUP0302664A3 (en)	2004-10-28
PT1307565E (pt)	2009-01-28
EA010721B1 (ru)	2008-10-30
ATE412055T1 (de)	2008-11-15
US20030165537A1 (en)	2003-09-04
EP1307565A2 (en)	2003-05-07
WO2002012288A3 (en)	2002-04-11
CZ303904B6 (cs)	2013-06-19
EA200300215A1 (ru)	2003-08-28
PL365190A1 (en)	2004-12-27
CN102151333A (zh)	2011-08-17
KR100633180B1 (ko)	2006-10-11
NZ524066A (en)	2004-11-26
HRP20030147A2 (en)	2005-04-30
HUP0302664A2 (hu)	2003-11-28
JP2004505993A (ja)	2004-02-26
US9073979B2 (en)	2015-07-07

Publication	Publication Date	Title
NO20030524D0 (no)	2003-02-03	Vaksine mot vertscelleassosiert herpesvirus
Mettenleiter	1991	Molecular biology of pseudorabies (Aujeszky's disease) virus
BR0014171A (pt)	2002-05-21	Composição
AU585126B2 (en)	1989-06-08	Recombinant herpes simplex viruses, vaccines and methods
ATE194657T1 (de)	2000-07-15	Bei einer transkomplementenden zellinie erzeugter defektiver virenimpfstoff
CA2166367A1 (en)	1996-07-01	Live recombinant avian vaccine using an avian herpesvirus as vector
WO1990002803A3 (en)	1990-05-31	Viral vaccines
BR0014172A (pt)	2002-05-14	Composição
AU3142889A (en)	1989-09-21	A recombinant marek's disease virus and a vaccine
EP0261940A3 (en)	1989-07-05	Pseudorabies vaccines and dna vectors for recombination with pox viruses
Field et al.	2006	Herpesvirus latency and therapy—from a veterinary perspective
CA2116355A1 (en)	1994-01-06	Infectious bovine rhinotracheitis virus mutants and vaccines
DE69226980D1 (de)	1998-10-22	Rekombinanter Varicella-Zoster-Virus-Vektor
DK0606452T3 (da)	2003-03-17	Vektorvacciner fra rekombinant katteherpesvirus
ATE317439T1 (de)	2006-02-15	Virale vakzine
Nagesha et al.	1993	Analysis of the nucleotide sequence of five genes at the left end of the unique short region of the equine herpesvirus 4 genome
EA200100720A1 (ru)	2002-02-28	Вирусная вакцина на основе делеционного вируса герпеса крупного рогатого скота типа 1 (bhv-1)
ATE93543T1 (de)	1993-09-15	Varicella-zoster-virus als lebende rekombinante vakzine.
ES2132330T3 (es)	1999-08-16	Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.
Becker	1994	Live Herpesvirus Vaccines: Serendipity or Engineering of the Virus Genome
岡崎和子 et al.	1990	The immunodominant glycoprotein complex of equid herpesvirus 1 (EHV-1) and the counterpart of EHV-4.
種子野章 et al.	1990	Immunological properties of the cell-associated live infectious laryngotracheitis virus.
WO2005009372A3 (en)	2005-04-14	Marek’s disease virus vaccine
Reddy et al.	2016	Novel insights in the pathogenesis of infectious laryngotracheitis and bronchitis viruses in chickens
Audonnet et al.	1998	Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease

Legal Events

Date	Code	Title	Description
2014-03-24	MM1K	Lapsed by not paying the annual fees